US Stem Cell Inc (USRM)

[GoldenMind]

US STEM CELL UPDATE 8/8/2017 8:14:40 pm Eastern

$USRM continues to lead the industry in regenerative medicine therapy procedures and revenues continue to grow. Last Quarter revs were up to $601k for services from $209k a 188% increase from March 2016. Now Revenues for services in June 2017 are up to $943k vs 313k in June 2016 a 195% increase. Still showing solid growth.

Per CEO in last blog "Overall, this summer has been one of great progress and success with many exciting opportunities in the near future. Look for press releases soon on our upcoming clinic openings in Palm Beach and Dallas" , so 2 new clinics opening soon along with Kuwait which is currently under construction.

Kuwait opening by end of year per 10Q today,
"The US Stem Cell Clinic in Kuwait is currently under construction and is expected to open before the end of the year" page 25

Last 5 Quarters say it all, $USRM is building something here. With tides shifting and politics looking favorable I am guessing guidelines from the FDA in September will be even more beneficial to US Stel Cell's mission.

https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/

ASSETS
$283k Jun 2016
$413k Sep 2016
$427k Dec 2016
$1385k Mar 2017
$1632k Jun 2017

Revenues
$678k Jun 2016
$729k Sep 2016
$964k Dec 2016
$1154k Mar 2017
$1386k Jun 2017 (Gross profit now $985k in Jun 2017 vs 443k last Jun 2016)

Cash and Cash Equivalents
$130k Jun 2016
$246k Sep 2016
$270k Dec 2016
$619k Mar 2017
$930k Jun 2017

336,461,515 shares issued and outstanding as of June 30, 2017 vs 327,613million last quarter. :)

Also, New Clinical trial completed and added July 20, 2017

Safety Analysis of Implantation of Stromal Vascular Fraction https://clinicaltrials.gov/ct2/show/NCT03226093?term=bioheart&rank=6

Enrollment: 676
Actual Study Start Date: January 1, 2015
Study Completion Date: June 1, 2017
Primary Completion Date: January 1, 2017 (Final data collection date for primary outcome measure)

WOW 676 enrolled.

Kristin released news about it in January but posted on Clinical trial site 2 weeks ago.

https://www.accesswire.com/453292/CSO-Kristin-Comella-Publishes-Paper-on-the-Implantation-of-Stromal-Vascular-Fraction-in-Patients-with-Degenerative-Disc-Disease

Trump just backed the right to try law!

http://dailysignal.com/2017/08/07/trump-backs-federal-right-to-try-law-already-enacted-in-37-states/



Also,
Phase 3 trial completion date changed to Feb 2019. Status set to active.

Us Stem Cell's MARVEL congestive heart failure Phase3 trial updated July 20, 2017

https://clinicaltrials.gov/archive/NCT00526253/2017_07_20

https://clinicaltrials.gov/archive/NCT00526253

$USRM


June was a record month for patients treated and stem cells banked, If that is the case we are looking at an even stronger month of growth for Q3,
"We have experienced continued success, growing patient satisfaction and clinic expansion, with June being a record month for number of patients treated and stem cells banked." per ceo in his last blog.

http://us-stemcell.com/ceo-blog-good-summer-at-ussc/